Testosterone Enanthate
Half-Life (t½) IM: 4.5d
Formula C26H40O3
Molecular Weight 400.59 g/mol
Aliases Delatestryl, Testosterone E Pharmacological Mechanism Testosterone esterified with enanthic acid (heptanoic acid, 7-carbon). Hydrolysed to free testosterone by esterases. Slightly shorter ester half-life than cypionate (4.5 d vs ~8 d) but overall clinical profile is equivalent in replacement use. European market standard; cypionate is US standard.
Half-Life & Elimination Curve (IM: 4.5d) 100% 50% 25% 12.5% 0% 0h 0×t½ 4.5d 1×t½ 9d 2×t½ 13.5d 3×t½ 18d 4×t½ 22.5d 5×t½ 0×t½ (0h): 100% remaining (~0.671 mg/L) 1×t½ (4.5d): 50% remaining (~0.336 mg/L) 2×t½ (9d): 25% remaining (~0.168 mg/L) 3×t½ (13.5d): 12.5% remaining (~83.9 µg/L) 4×t½ (18d): 6.3% remaining (~42 µg/L) 5×t½ (22.5d): 3.1% remaining (~21 µg/L) Plasma (IM) t½ Decay (4.5d)
0×t½ 0h 100% (0.671 mg/L) 1×t½ 4.5d 50% (0.336 mg/L) 2×t½ 9d 25% (0.168 mg/L) 3×t½ 13.5d 12.5% (83.9 µg/L) 4×t½ 18d 6.3% (42 µg/L) 5×t½ 22.5d 3.1% (21 µg/L) Dosing Guidelines Intramuscular (IM): Typical 133 mg (Range: 100–200 mg)Pharmacokinetic Parameters Intramuscular (IM): Bioavailability (F): 95% · Volume of Distribution (Vd): 77 L · Absorption (ka): 0.008 h⁻¹ (t½ka ≈ 3.6d) [PMID 6800853 ]Pathways It Modulates Target Organ Systems Interactions Chemical Structure & Identifiers InChIKey: VOCBWIIFXDYGNZ-IXKNJLPQSA-NSMILES: CCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)CReferences Directory Compounds Registry Human Biology Hub